The risk of lower extremity arterial disease was increased (OR = 1.17, 95 % CI 1.09-1.28, p < 0.001) with each SD higher level of OPG in patients with type 2 diabetes after adjustment for traditional CVD risk factors (Table 3). Here, TNFRSF11B is linked to type 2 diabetes mellitus.